Equity Research Bottled & Canned Soft Drinks & Carbonated Waters

Should You Buy Coca-Cola Europacific Partners Stock in 2026?

By CirclFi Research Team · · 12/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Coca-Cola Europacific Partners (CCEP) is rated as a strong fundamental performer with a QOC score of 8.6/10. Trading at $106.14, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.

The short answer: 3 of 12 CirclFi valuation models project upside for Coca-Cola Europacific Partners (CCEP) at $106.14 — the model consensus leans bearish, with a Quality Score of 8.6/10 and Value-Trap risk of —/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 9 of 12 models suggest overvaluation — majority bearish
  • Quality Score: 8.6/10 — Excellent — top-tier fundamentals
  • Value Trap Risk: —/100 — Not scored
  • Fair Value Range: $33.81 – $267.95 (693% spread)

Bullish Models

3 / 12

Bearish Models

9 / 12

Quality Score

8.6 /10

Excellent — top-tier fundamentals

Value Trap Risk

/100
Not scored

Not scored

Model Consensus

12 /13
Active Models

Avg. confidence: 46%

Investment Thesis

The Bull Case

Target: $267.95 (+152.4% upside)

  • According to the CirclFi Quality of Company (QOC) framework, Coca-Cola Europacific Partners 's score of 8.6/10 reflects durable competitive advantages that should sustain earnings power through market cycles.
  • According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model targets a fair value of $267.95 (+152.4%), anchoring the bull case with a methodology that provides a differentiated analytical lens.
  • Industry tailwind: clean energy transition investment could provide meaningful support for Coca-Cola Europacific Partners 's revenue and margin trajectory in the Bottled & Canned Soft Drinks & Carbonated Waters space.

The Bear Case

Target: $33.81 (-68.1%)

  • According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $33.81 (-68.1%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +220.6% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.
  • Industry headwind: regulatory disallowance represents a meaningful risk for Coca-Cola Europacific Partners and its Bottled & Canned Soft Drinks & Carbonated Waters peers.

Peer Benchmarking

COKE Coca-Cola Consolidat
10.0
MNST Monster Beverage Cor
9.3
FIZZ National Beverage Co
9.0
CELH Celsius Holdings, In
8.7
FMX Fomento Economico Me
8.4

Valuation Divergence

Spread

693%

Fair Value Range

$33.81 – $267.95

A 693% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Markov DDM

$267.95 (+152.4%)

Most Bearish

EROIC

$33.81 (-68.1%)

Key Risk Factors

Model Disagreement

693% spread signals high variance in projections.

Bearish Consensus

9/12 models suggest overvaluation.

Macro/Sector Risk

Bottled & Canned Soft Drinks & Carbonated Waters headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View CCEP Data Page →

The Bottom Line

Caution dominates our read on Coca-Cola Europacific Partners at $106.14. 8 of 12 models see limited upside or outright downside, with the composite fair value at $100.71 (-5.1%). Quality at 8.6/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.

These are quantitative model outputs, not investment recommendations. Coca-Cola Europacific Partners 's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy CCEP stock right now?

Based on CirclFi's multi-model analysis, 3 of 12 models see upside for CCEP at $106.14. The models are divided, which means the investment case depends heavily on your assumptions about Coca-Cola Europacific Partners 's future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Coca-Cola Europacific Partners ?

Key risks include: wide model disagreement (693% spread), signaling high uncertainty; general market and sector-specific risks affecting Bottled & Canned Soft Drinks & Carbonated Waters companies. Always diversify and consult a financial advisor.

How does CCEP compare to its competitors?

Among Bottled & Canned Soft Drinks & Carbonated Waters peers, CCEP holds a Quality Score of 8.6/10. Comparable companies include COKE (QOC 10.0), MNST (QOC 9.3), FIZZ (QOC 9.0). The relative ranking helps investors identify whether CCEP offers better fundamental quality than alternatives in the same sector.

Is CCEP a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CCEP's Quality Score of 8.6/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy CCEP at?

CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $33.81 to $267.95. At $106.14, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for CCEP.

View CCEP Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →